Skip to main content

Don't overlook the impact of pharma tariffs, says an analyst. Where we stand on Bristol Myers

The drug stock is higher over the past month while the S&P 500 has pulled back sharply.

from US Top News and Analysis https://ift.tt/9VziJhP

Comments

Popular posts from this blog